US5908783A - Alternating lysine-alanine copolymer substrate for promoting neuron survival and axon growth - Google Patents
Alternating lysine-alanine copolymer substrate for promoting neuron survival and axon growth Download PDFInfo
- Publication number
- US5908783A US5908783A US08/984,742 US98474297A US5908783A US 5908783 A US5908783 A US 5908783A US 98474297 A US98474297 A US 98474297A US 5908783 A US5908783 A US 5908783A
- Authority
- US
- United States
- Prior art keywords
- lysine
- substrate
- copolymer
- las
- lys
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000758 substrate Substances 0.000 title claims abstract description 55
- 229920001577 copolymer Polymers 0.000 title claims abstract description 29
- 230000001737 promoting effect Effects 0.000 title claims abstract description 6
- 230000028600 axonogenesis Effects 0.000 title abstract description 6
- 230000032405 negative regulation of neuron apoptotic process Effects 0.000 title abstract description 6
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims abstract description 39
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 claims abstract description 18
- 239000004472 Lysine Substances 0.000 claims abstract description 14
- 210000002569 neuron Anatomy 0.000 claims description 23
- 239000007787 solid Substances 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 7
- 239000011521 glass Substances 0.000 claims description 6
- 210000003050 axon Anatomy 0.000 claims description 5
- 230000012010 growth Effects 0.000 claims description 4
- 229920003023 plastic Polymers 0.000 claims description 4
- 239000004033 plastic Substances 0.000 claims description 4
- 239000004793 Polystyrene Substances 0.000 claims description 2
- 229920002223 polystyrene Polymers 0.000 claims description 2
- 230000035899 viability Effects 0.000 claims description 2
- 238000012258 culturing Methods 0.000 claims 2
- 230000001537 neural effect Effects 0.000 claims 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 35
- 210000004027 cell Anatomy 0.000 description 29
- KDXKERNSBIXSRK-RXMQYKEDSA-N D-lysine Chemical compound NCCCC[C@@H](N)C(O)=O KDXKERNSBIXSRK-RXMQYKEDSA-N 0.000 description 28
- 235000018977 lysine Nutrition 0.000 description 18
- 230000004083 survival effect Effects 0.000 description 16
- 108010026424 tau Proteins Proteins 0.000 description 15
- 102000013498 tau Proteins Human genes 0.000 description 15
- 108090000765 processed proteins & peptides Proteins 0.000 description 14
- 239000000835 fiber Substances 0.000 description 12
- 108010039918 Polylysine Proteins 0.000 description 10
- 229920000656 polylysine Polymers 0.000 description 10
- 102000004196 processed proteins & peptides Human genes 0.000 description 9
- 101000979001 Homo sapiens Methionine aminopeptidase 2 Proteins 0.000 description 8
- 101000969087 Homo sapiens Microtubule-associated protein 2 Proteins 0.000 description 8
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 8
- 102100021118 Microtubule-associated protein 2 Human genes 0.000 description 8
- 235000004279 alanine Nutrition 0.000 description 8
- 229920000642 polymer Polymers 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 230000004069 differentiation Effects 0.000 description 6
- 150000002669 lysines Chemical class 0.000 description 6
- 229920005604 random copolymer Polymers 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 238000004113 cell culture Methods 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 230000011987 methylation Effects 0.000 description 5
- 238000007069 methylation reaction Methods 0.000 description 5
- 229920001184 polypeptide Polymers 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000002983 circular dichroism Methods 0.000 description 4
- 210000004295 hippocampal neuron Anatomy 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000007792 addition Methods 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- NNTOJPXOCKCMKR-UHFFFAOYSA-N boron;pyridine Chemical compound [B].C1=CC=NC=C1 NNTOJPXOCKCMKR-UHFFFAOYSA-N 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 230000003436 cytoskeletal effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229930195712 glutamate Natural products 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 229920000768 polyamine Polymers 0.000 description 3
- 108020003175 receptors Proteins 0.000 description 3
- 102000005962 receptors Human genes 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 241000283707 Capra Species 0.000 description 2
- 108090000368 Fibroblast growth factor 8 Proteins 0.000 description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 239000005700 Putrescine Substances 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- 239000013504 Triton X-100 Substances 0.000 description 2
- 229910021538 borax Inorganic materials 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000000971 hippocampal effect Effects 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 102000006495 integrins Human genes 0.000 description 2
- 108010044426 integrins Proteins 0.000 description 2
- 108010074572 lysine-alanine sequential polymer Proteins 0.000 description 2
- 210000003061 neural cell Anatomy 0.000 description 2
- 230000023362 neuron cell-cell adhesion Effects 0.000 description 2
- 102000005162 pleiotrophin Human genes 0.000 description 2
- 238000006485 reductive methylation reaction Methods 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 235000010339 sodium tetraborate Nutrition 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 2
- PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 238000012353 t test Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- RVLOMLVNNBWRSR-KNIFDHDWSA-N (2s)-2-aminopropanoic acid;(2s)-2,6-diaminohexanoic acid Chemical compound C[C@H](N)C(O)=O.NCCCC[C@H](N)C(O)=O RVLOMLVNNBWRSR-KNIFDHDWSA-N 0.000 description 1
- CHADEQDQBURGHL-UHFFFAOYSA-N (6'-acetyloxy-3-oxospiro[2-benzofuran-1,9'-xanthene]-3'-yl) acetate Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(OC(C)=O)C=C1OC1=CC(OC(=O)C)=CC=C21 CHADEQDQBURGHL-UHFFFAOYSA-N 0.000 description 1
- NHJVRSWLHSJWIN-UHFFFAOYSA-N 2,4,6-trinitrobenzenesulfonic acid Chemical compound OS(=O)(=O)C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O NHJVRSWLHSJWIN-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- QUIGLPSHIFPEOV-CIUDSAMLSA-N Ala-Lys-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O QUIGLPSHIFPEOV-CIUDSAMLSA-N 0.000 description 1
- 241000024188 Andala Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 101100315624 Caenorhabditis elegans tyr-1 gene Proteins 0.000 description 1
- 102000016289 Cell Adhesion Molecules Human genes 0.000 description 1
- 108010067225 Cell Adhesion Molecules Proteins 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 102100021238 Dynamin-2 Human genes 0.000 description 1
- 241000416536 Euproctis pseudoconspersa Species 0.000 description 1
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 1
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 1
- 102100037362 Fibronectin Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 241000287227 Fringillidae Species 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 229920002971 Heparan sulfate Polymers 0.000 description 1
- 101000817607 Homo sapiens Dynamin-2 Proteins 0.000 description 1
- QOOWRKBDDXQRHC-BQBZGAKWSA-N L-lysyl-L-alanine Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN QOOWRKBDDXQRHC-BQBZGAKWSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 102000009664 Microtubule-Associated Proteins Human genes 0.000 description 1
- 108010020004 Microtubule-Associated Proteins Proteins 0.000 description 1
- 241000713333 Mouse mammary tumor virus Species 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 108010033276 Peptide Fragments Proteins 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 229920005603 alternating copolymer Polymers 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 150000001484 arginines Chemical class 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003376 axonal effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- QVYARBLCAHCSFJ-UHFFFAOYSA-N butane-1,1-diamine Chemical group CCCC(N)N QVYARBLCAHCSFJ-UHFFFAOYSA-N 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 238000001142 circular dichroism spectrum Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 210000004292 cytoskeleton Anatomy 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010252 digital analysis Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- -1 dimethyl lys Chemical compound 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000012744 immunostaining Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 229920001303 methylated polymer Polymers 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 210000002241 neurite Anatomy 0.000 description 1
- 230000014511 neuron projection development Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 229920000729 poly(L-lysine) polymer Polymers 0.000 description 1
- 229920000307 polymer substrate Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 210000001176 projection neuron Anatomy 0.000 description 1
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000000611 regression analysis Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 239000012679 serum free medium Substances 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 229940063673 spermidine Drugs 0.000 description 1
- 229940063675 spermine Drugs 0.000 description 1
- 238000012453 sprague-dawley rat model Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0619—Neurons
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0068—General culture methods using substrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
- C12N2533/32—Polylysine, polyornithine
Definitions
- the field of the present invention is copolymer substrates for use in cell culture. More particularly, the field of the present invention relates to substrates containing copolymers of alternating lysine and alanine residues and the use of such substrates for promoting neuron survival and axon growth.
- polylysine substrates are able to promote neuron adhesion and differentiation.
- polylysine does not appear to mimic adhesive brain proteins that are known to stimulate differentiation. These proteins that stimulate differentiation, including laminin, pleiotrophin (HB-GAM), L1 and N-CAM, are distinguishable from polylysine because they do not contain sequences of polylysine or other basic residues.
- HB-GAM pleiotrophin
- L1 and N-CAM are distinguishable from polylysine because they do not contain sequences of polylysine or other basic residues.
- Copolymers of lysine and alanine have not previously been reported as effective substrates for neurons or other cells.
- Other polypeptides containing the integrin binding site for fibronectin, RGD (Varani et al., 1993) have proven to be effective substrates for fibroblasts and other cells
- a ten-residue peptide fragment of laminin promotes neurite outgrowth (Liesi et al., 1989).
- An antibody to a 14 residue peptide from the L1 adhesion molecule increases neuritogenesis (Appel et al., 1995), probably through an integrin mediated receptor (Montgomery et al., 1996).
- LAS Short polypeptides of lysine and alanine have been shown to bind strongly to DNA (Takeuchi et al., 1991), but this is not likely to be the mechanism by which substrate-bound LAS stimulates survival and axongenesis in neurons.
- LAS may be a model for naturally occurring polyamine such as spermidine, spermine and putrescine (Morrison et al., 1995).
- B27 medium, as well as the N2 medium of Bottenstein and Sato (1979) contains putrescine. Chu et al. (1995a) have shown that the butanediamine structure of these polyamine is required for enhanced survival of hippocampal neurons when added to the culture medium.
- the present invention is for a novel substrate containing a copolymer of sequentially alternating lysine-alanine amino acid residues.
- the copolymer has molecular weight less than about 30,000 Daltons.
- the substrate promotes neuron survival and axon growth.
- the present invention is directed to a process for promoting neuron survival and axon growth using such substrates.
- FIGS. 2A and B Show that (A) the length of longest tau reactive fiber is greater for neurons cultured on LAS (solid circles) compared to ply-D-lysine (open circles). The difference is seen for neurons in culture for 1, 2 or 4 days. Representative of 3 experiments. At longer times, (B) total immunoreactive area for tau was greater for neurons cultured on LAS (solid circles) compared to poly-D-lysine (open circles).
- FIG. 4. Shows the circular dichroism spectra for (A) poly-D-lysine, (B) LAS, and (C) lys, ala random polymers at 0.1 mg/ml in 10 mM sodium phosphate, 150 mM NaCl, pH 7.4. The trough near 225 nm indicates some alpha-helical nature for lys, ala. The flat signal in the 220-240 nm range indicates random coil conformation.
- the present invention provides a substrate for cell culture, which substrate includes a copolymer of sequentially alternating lysine and alanine residues.
- a copolymer of sequentially alternating lysine and alanine residues As used herein, the phrase “sequentially alternation” means a sequence of amino acid residues having only lysine (Lys) and alanine (Ala) residues, which lysine and alanine residues exist as repeating pairs.
- the copolymer can, therefore, be represented by the formula (Lys-Ala) n or the formula (Ala-Lys) n , where n is an integer greater than zero.
- the copolymer has a molecular weight of less than about 30,000 Daltons (i.e., there are less than about 150 repeating Lys-Ala pairs). More preferably, the copolymer has a molecular weight of less than about 20,000, 10,000, 5,000, 2,500, 1,500, or 1,000 Daltons.
- the copolymer of this invention can be linear or branched. Means for making Lys-Ala copolymers are well known in the art.
- the substrate further includes a solid support.
- the solid support is coated with the copolymer such that the coated surface is exposed to cells or tissue for culture.
- Any solid support known in the art can be used.
- Exemplary and preferred solid supports are glass and plastic such as polystyrene.
- Means for coating a solid support with copolymers are well known in the art.
- a substrate of this invention can be used to culture any cell.
- the substrate has particular utility with neural cells and tissues.
- the effects of Lys-Ala copolymer substrates on neural cell growth and viability were studied.
- Three types of substrates were prepared by adsorption of polypeptides from varying aqueous concentrations: (1) poly-D-lysine, (2) a random copolymer of lysine and alanine (Lys,Ala), and (3) a sequential copolymer of lysine and alanine (Lys-Ala).
- poly-D-lysine (70,000-150,000 MW, P6407)
- random Lys,Ala 1:1 (P4024)
- Lys-Ala sequential copolymer (LAS, average MW 14,500, P5209).
- Sequential polymers were synthesized according to Engel et al. (1966).
- Peptides were dissolved at 1 mg/ml in 18 megohm water and stored at -20° C. After thawing and dilution to 50 ⁇ g/ml, unless otherwise indicate, either 0.1 ml was applied to each 12 mm D glass coverslip (Assistent brand, Carolina Biologicals, Burlington) or 0.3 ml was added to each well of 24 well cell culture plate (Corning 4,30262). After incubation overnight at room temperature, substrates were rinsed once with equal volumes of sterile water and allowed to dry.
- LAS Lys-Ala sequential copolymer
- the morphology of neurons grown on LAS was dramatically different from those grown on conventional poly-D-lysine. Fibers emanating from the soma were of more uniform caliber, longer and thinner on LAS than on PDL. Cells were immunostained to determine whether these axon-like qualities were associated with the characteristic cytoskeletal protein, tau, or the somatodendritic protein MAP2 (Kosik & Finch, 1987). Neurons on LAS showed a typical higher proportion of narrow fibers selectively labeled for tau as well as labeling go tau in the nucleus (Thurston et al., 1996) and somatodendritic labeling of tau and MAP2. Neurons on poly-D-lysine showed mostly coincident labeling of tau and MAP2.
- HBS Hanks buffered salts
- PBS PBS
- cells were dehydrated for 1 min. With 10% ethanol in water, followed by 30, 50, 70, 85, 95 (twice) and 100% (trice) ethanol. Samples were dried at the critical point of CO 2 , with a 10 min. purge. Cells were examined on a Hitachi S500 at 20 kV and 5 mm working distance.
- reductive methylation was performed by modification of the method of Kielland et al. (1978). Triplicate samples of peptides were dissolved at 1 mg/ml in 0.2 M sodium borate, ph 9.0. One ml aliquots were treated at 24° C. with 0.01 ml 2 M borane-pyridine (Aldrich 17,975-2) in methanol. After ten min., 0.01 ml 2.5 M formaldehyde, 0.2 M sodium borate, pH 9.0 was added. This sequence of additions of borane-pyridine and formaldehyde was repeated three more times, followed by a final addition of borane-pyridine.
- the solution conformation of LAS, poly-D-lysine and random Lys,Ala polymer were determined by circular dichroism.
- samples were dissolved at 0.1 mg/ml in 10 mM sodium phosphate, 150 mM NaCl, pH 7.4.
- Spectra were collected from three scans on a Jasco J-600 spectropolarimeter.
- FIG. 4 shows spectra characteristic of random coil conformation for both LAS and poly-D-lysine. In contrast, the peak near 222 nm indicates some alpha-helical content for the random polymer Lys, Ala.
- the cell receptor that binds to poly-D-lysine or LAS is not known. It is not known whether the apparent 15% branching detected in LAS is important for the survival and cytoskeletal simulation. Circular dichroism studies show a random coil conformation for LAS and poly-D-lysine in PBS. However, the conformation on the substrate may be that of a beta sheet. In a beta sheet conformation of an alternating neutral and basic amino acid, the positive charges on the epsilon amino groups of lysines could align on one side of the sheet. The opposite side would be highly hydrophobic side chains of alanine.
- a possible neuron receptor may involve chondroitin sulfate attached to a membrane plycoprotein, with sulfate groups spaced an average of 4 ⁇ .
- the carboxyl and sulfate groups of heparin sulfate average 4 ⁇ along the chain (Mulloy et al., 1993); a finding consistent with the x-ray structure for the complex of heparin and basic fibroblast growth factor (Faham et al., 1996).
- lysines or arginines interact with sulfates of carboxylates at distances of 4.4 to 11 ⁇ (R. Hileman, personal communication).
- LAS is synthesized without protection of the lysine ⁇ -amino group, which allows limited branching of he polymer.
- Amino acid analysis before and after reductive methylation was used to measure the degree of branching. Table 1, below, shows the equimolar composition of LAS and Lys,Ala before methylation. Table 1. Amino acid analysis before and after methylation for branch points ( ⁇ mol/mg)
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Peptides Or Proteins (AREA)
- Polyamides (AREA)
Abstract
Description
______________________________________ unmethyl- methylated polymers ated ε-N,N- % un- sample ala lys ala lys dimethyl lys methylated.sup.a ______________________________________ poly--D--lys 4.4 <0.1 4.4 <1 lys,ala 3.2 3.2 3.1 <0.1 3.4 <3 LAS 3.7 3.55 3.45 0.55 1.65 15 ______________________________________ .sup.a % unmethylated = 100* lys after methylation/lys unmethylated
Claims (12)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/984,742 US5908783A (en) | 1997-12-04 | 1997-12-04 | Alternating lysine-alanine copolymer substrate for promoting neuron survival and axon growth |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/984,742 US5908783A (en) | 1997-12-04 | 1997-12-04 | Alternating lysine-alanine copolymer substrate for promoting neuron survival and axon growth |
Publications (1)
Publication Number | Publication Date |
---|---|
US5908783A true US5908783A (en) | 1999-06-01 |
Family
ID=25530814
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/984,742 Expired - Fee Related US5908783A (en) | 1997-12-04 | 1997-12-04 | Alternating lysine-alanine copolymer substrate for promoting neuron survival and axon growth |
Country Status (1)
Country | Link |
---|---|
US (1) | US5908783A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6506576B2 (en) | 2001-03-14 | 2003-01-14 | Board Of Trustees Of The University Of Arkansas | Serum-and steroid-free culture media for cerebellar granule neurons |
US20060018947A1 (en) * | 2000-10-28 | 2006-01-26 | Erhard Mueller | Bioresorbable nerve guide rail |
US7101565B2 (en) | 2002-02-05 | 2006-09-05 | Corpak Medsystems, Inc. | Probiotic/prebiotic composition and delivery method |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4415492A (en) * | 1980-08-29 | 1983-11-15 | Alain L. de Weck | Lysine polymers which may be used as supports for the preparation of products of diagnosis and products obtained |
US5147399A (en) * | 1988-02-01 | 1992-09-15 | Dellon Arnold L | Method of treating nerve defects through use of a bioabsorbable surgical device |
US5444150A (en) * | 1991-06-14 | 1995-08-22 | The United States Of America As Represented By The Department Of Health And Human Services | Amino acid derivative and bromoacetyl modified peptides for the preparation of synthetic peptide polymers, conjugated peptides, and cyclic peptides |
US5543498A (en) * | 1993-12-07 | 1996-08-06 | The General Hospital Corporation | Peptides to overcome inhibition of nerve growth |
US5656605A (en) * | 1994-01-26 | 1997-08-12 | Institute Of Molecular Biology, Inc. | Device to promote drug-induced nerve regeneration |
-
1997
- 1997-12-04 US US08/984,742 patent/US5908783A/en not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4415492A (en) * | 1980-08-29 | 1983-11-15 | Alain L. de Weck | Lysine polymers which may be used as supports for the preparation of products of diagnosis and products obtained |
US5147399A (en) * | 1988-02-01 | 1992-09-15 | Dellon Arnold L | Method of treating nerve defects through use of a bioabsorbable surgical device |
US5444150A (en) * | 1991-06-14 | 1995-08-22 | The United States Of America As Represented By The Department Of Health And Human Services | Amino acid derivative and bromoacetyl modified peptides for the preparation of synthetic peptide polymers, conjugated peptides, and cyclic peptides |
US5543498A (en) * | 1993-12-07 | 1996-08-06 | The General Hospital Corporation | Peptides to overcome inhibition of nerve growth |
US5656605A (en) * | 1994-01-26 | 1997-08-12 | Institute Of Molecular Biology, Inc. | Device to promote drug-induced nerve regeneration |
Non-Patent Citations (18)
Title |
---|
Banker et al., "Rat hippocampal neurons in dispersed cell culture", Brain Research, 1977, 126, pp. 397-425. |
Banker et al., Rat hippocampal neurons in dispersed cell culture , Brain Research, 1977, 126, pp. 397 425. * |
Brack et al., "B structures of alternating polypeptides and their possible prebiotic significance," Nature, vol. 256, 1975, pp. 383-387. |
Brack et al., B structures of alternating polypeptides and their possible prebiotic significance, Nature , vol. 256, 1975, pp. 383 387. * |
Brewer et al., "Survival and growth of hippocampal neurons in defined medium at low density: advantages of a sandwich culture technique or low oxygen", Brain research, 1989, 494, pp. 65-74. |
Brewer et al., Survival and growth of hippocampal neurons in defined medium at low density: advantages of a sandwich culture technique or low oxygen , Brain research, 1989, 494, pp. 65 74. * |
Chu et al, "Polyamines promotes regeneration of injured axons of cultured rat hippocampal neurons", Brain Research, 1995, 673, pp. 233-241. |
Chu et al, Polyamines promotes regeneration of injured axons of cultured rat hippocampal neurons , Brain Research, 1995, 673, pp. 233 241. * |
Johnson, "Synthesis, Structure, and Biological Properties of Sequential Polypeptides," Journal of Pharmaceutical Sciences, 1974, pp. 313-327. |
Johnson, Synthesis, Structure, and Biological Properties of Sequential Polypeptides, Journal of Pharmaceutical Sciences , 1974, pp. 313 327. * |
Kielland et al., "Water-soluble lysine-containing polypeptides", Can. J. Chem. 1978, 56 (20), pp. 2650-2656. |
Kielland et al., Water soluble lysine containing polypeptides , Can. J. Chem. 1978, 56 (20), pp. 2650 2656. * |
Varani et al., "Use of recombinant and synthtic peptides as attachment factors for cells on microcarriers," Cytotechnology, vol. 13, 1993, pp. 89-98. |
Varani et al., Use of recombinant and synthtic peptides as attachment factors for cells on microcarriers, Cytotechnology , vol. 13, 1993, pp. 89 98. * |
Yaron et al., "Sequential Polypeptide (LYS-ALA-ALA)n, Synthesis and Conformation," Israel J. Chem., vol. 8, 1970, p. 180p. |
Yaron et al., Sequential Polypeptide (LYS ALA ALA)n, Synthesis and Conformation, Israel J. Chem. , vol. 8, 1970, p. 180p. * |
Yong et al., "Comparison of six different substrata on the plating efficiency, differentiation and survival of human dorsal root ganglion neurons in culture", Dev. Neursci., 1988, 10, pp. 222-230. |
Yong et al., Comparison of six different substrata on the plating efficiency, differentiation and survival of human dorsal root ganglion neurons in culture , Dev. Neursci., 1988, 10, pp. 222 230. * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060018947A1 (en) * | 2000-10-28 | 2006-01-26 | Erhard Mueller | Bioresorbable nerve guide rail |
US7198799B2 (en) * | 2000-10-28 | 2007-04-03 | Deutsche Institute für Textil-und Faserforschung Stuttgart Stiftung des Oeffentlichen Rechts | Bioresorbable nerve guide rail |
US6506576B2 (en) | 2001-03-14 | 2003-01-14 | Board Of Trustees Of The University Of Arkansas | Serum-and steroid-free culture media for cerebellar granule neurons |
US7101565B2 (en) | 2002-02-05 | 2006-09-05 | Corpak Medsystems, Inc. | Probiotic/prebiotic composition and delivery method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
VandeVondele et al. | RGD‐grafted poly‐l‐lysine‐graft‐(polyethylene glycol) copolymers block non‐specific protein adsorption while promoting cell adhesion | |
Yu et al. | Peptide surface modification of methacrylamide chitosan for neural tissue engineering applications | |
DE69011102T2 (en) | HYDROPHOBIC BINDING POINT FOR ADHESION PEPTIDES. | |
Zhang et al. | Neurite outgrowth on well-characterized surfaces: preparation and characterization of chemically and spatially controlled fibronectin and RGD substrates with good bioactivity | |
DE69030730T2 (en) | SURFACES WITH DESIRED CELL LIABILITY EFFECTS | |
Smith et al. | Maturation of astrocytes in vitro alters the extent and molecular basis of neurite outgrowth | |
Moore et al. | Synergistic enhancement of human bone marrow stromal cell proliferation and osteogenic differentiation on BMP-2-derived and RGD peptide concentration gradients | |
Tong et al. | Enhancing the neuronal interaction on fluoropolymer surfaces with mixed peptides or spacer group linkers | |
Frisen et al. | Spinal axons in central nervous system scar tissue are closely related to laminin-immunoreactive astrocytes | |
Acharya et al. | The effect of lactose-conjugated silk biomaterials on the development of fibrogenic fibroblasts | |
Holland et al. | Culture of human vascular endothelial cells on an RGD-containing synthetic peptide attached to a starch-coated polystyrene surface: comparison with fibronectin-coated tissue grade polystyrene | |
Hynes et al. | A library of tunable poly (ethylene glycol)/poly (l‐lysine) hydrogels to investigate the material cues that influence neural stem cell differentiation | |
US7875591B2 (en) | Delivery system for heparin-binding growth factors | |
DE3885313T2 (en) | Peptides with laminin activity. | |
Karakeçili et al. | Enhancement of fibroblastic proliferation on chitosan surfaces by immobilized epidermal growth factor | |
Cattaneo et al. | Nuclear localization of a lactic dehydrogenase with single-stranded DNA-binding properties | |
Ruiz et al. | Phosphorylcholine-containing polyurethanes for the control of protein adsorption and cell attachment via photoimmobilized laminin oligopeptides | |
Okur et al. | Promotion of neurite outgrowth by rationally designed NGF-β binding peptide nanofibers | |
Bertolotto et al. | Monoclonal antibodies to keratan sulfate immunolocalize ramified microglia in paraffin and cryostat sections of rat brain. | |
US5908783A (en) | Alternating lysine-alanine copolymer substrate for promoting neuron survival and axon growth | |
Kim et al. | Preparation of insulin-immobilized polyurethanes and their interaction with human fibroblasts | |
Okada et al. | Histological and immunohistochemical study of idiopathic epiretinal membrane | |
US6800296B1 (en) | Modification of surfaces using biological recognition events | |
Burgeson | The Collagens of Skin¹ | |
Brewer et al. | Precocious axons and improved survival of rat hippocampal neurons on lysine–alanine polymer substrates |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: SOUTHERN ILLINOIS, UNIVERSITY, BOARD OF TRUSTEES,T Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BREWER, GREGORY J.;REEL/FRAME:008900/0734 Effective date: 19971203 |
|
FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
FPAY | Fee payment |
Year of fee payment: 8 |
|
REMI | Maintenance fee reminder mailed | ||
LAPS | Lapse for failure to pay maintenance fees | ||
LAPS | Lapse for failure to pay maintenance fees |
Free format text: PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES (ORIGINAL EVENT CODE: EXP.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
STCH | Information on status: patent discontinuation |
Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |
|
FP | Lapsed due to failure to pay maintenance fee |
Effective date: 20110601 |